Skip to content

ABILITY - TelerehABILITation: TechnologY-enhanced Multi-domain at Home Continuum of Care Program

ABILITY - TelerehABILITation. TechnologY-enhanced Multi-domain at Home Continuum of Care Program for People With Cognitive Impairment.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02746484
Enrollment
30
Registered
2016-04-21
Start date
2015-04-30
Completion date
2016-10-31
Last updated
2017-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer Disease, Cognitive Impairments, Dementia

Brief summary

The Ability research project, funded in Italy within the Smart Cities and Smart Communities funding program (MInistry of University and Research, Operational Regional Programme, Lombardy, Axis 1, Operational Regional Programme - European Funding for Regional Development 2007-2013), aims at developing and testing the efficacy and the impact of a Personal Smart Health Community able to provide innovative trajectories for people with cognitive impairment, putting them at the core of a continuous and intertwining treatment and support from both formal (e.g. physicians) and informal (e.g. near relatives) caregivers, with special focus on home-based care. Within this framework of the Ability project the investigators test the efficacy of the home-based motor-cognitive rehabilitation program delivered with two different approaches: the Ability platform versus the usual care program

Interventions

OTHERAbility platform program

The Ability program is an at home participant-tailored and technology-enhanced platform a) delivering tablet-based intensive (five days/a week for six weeks) motor and cognitive activities; b) monitoring from remote vital and physical health parameters (i.e., weight, Heart Rate, O2 saturation, daily steps, sleep activity).

Usual care at home program (paper and pencil cognitive activities; promotion of physical activity according to healthcare professional's advice)

Sponsors

University of Milano Bicocca
CollaboratorOTHER
Fondazione Don Carlo Gnocchi Onlus
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
65 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* diagnosed as mild AD or MCI due to AD (Albert et al, 2011) according to DSM 5 diagnostic criteria (American Psychiatric Association, 2013); * MMSE score \>18 * school attendance (≥ 3 years).

Exclusion criteria

* dysmetria; * serious deficits in visual acuity, acoustic perception, and in routine communication skills.

Design outcomes

Primary

MeasureTime frameDescription
activities of daily livingchange from baseline after 8 weeks (aMCI/AD subjects)Activities of Daily Living Inventory (ADCS/ADL)
behavioral symptomschange from baseline after 8 weeks (aMCI/AD subjects)Neuropsychiatric Inventory (NPI) score
cognitive domain (long-term memory)change from baseline after 8 weeks (aMCI/AD subjects)Free and Cued Selective Recall Test (FCSRT) score
cognitive domain (language)change from baseline after 8 weeks (aMCI/AD subjects)Fluency score
cognitive domain (frontal-executive functions)change from baseline after 8 weeks (aMCI/AD subjects)Trail Making Test (TMT) score
quality of lifechange from baseline after 8 weeks (aMCI/AD subjects)Dementia Quality of Life (D-QoL) Instrument
coping strategieschange from baseline after 8 weeks (aMCI/AD subjects)Coping Orientation for Problems Experienced - Brief Version (Brief COPE)
global cognitive levelchange from baseline after 12 months (aMCI/AD subjects)Montreal Cognitive Asssessment (MoCA) score

Secondary

MeasureTime frameDescription
caregiver coping strategieschange from baseline after 8 weeks and after 12 monthsCoping Orientation for Problems Experienced - Brief Version (Brief COPE)
activities of daily livingchange from baseline after 12 months (aMCI/AD subjects)Activities of Daily Living Inventory (ADCS/ADL)
caregiver affectchange from baseline after 8 weeks and after 12 monthsPositive and Negative Affect Schedule (PANAS)
caregiver burdenchange from baseline after 8 weeks and after 12 monthsCaregiver Burden Inventory (CBI)
conversion rate MCI versus ADchange from baseline after 12 months (aMCI subjects)conversion rate score
cognitive domain - long term memorychange from baseline after 12 months (aMCI/AD subjects)Free and Cued Selective Recall Test (FCSRT) score
cognitive domain - languagechange from baseline after 12 months (aMCI/AD subjects)Fluency score
cognitive domain - frontal executive functionschange from baseline after 12 monthsTrail Making Test (TMT) score
quality of lifechange from baseline after 12 monthsDementia Quality of Life (D-QoL) Instrument
coping strategieschange from baseline after 12 monthsCoping Orientation for Problems Experienced - Brief Version (Brief COPE)
caregiver quality of lifechange from baseline after 8 weeks and after 12 monthsPsychological Well-Being (PWB) scale

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 11, 2026